Satellos Bioscience Common Stock Common Stock

Satellos Bioscience Common Stock (MSLE) currently reports a common stock of $130M as of March 2026. That compares with $78M in the prior-year period — up 71.9% year over year. Use the charts on this page to explore Satellos Bioscience Common Stock's common stock history and peer comparisons.

Satellos Bioscience Common Stock's common stock increased from $78M to $130M — a 71.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Satellos Bioscience Common Stock reported $130M in common stock as of March 2026. That compares with $78M in the prior-year period — up 71.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Satellos Bioscience Common Stock, and consider following MSLE for alerts when major investors trade the stock.